Venue: Puerto Vallarta

Location: Puerto Vallarta, Mexico

Event Date/Time: Jun 06, 2010 End Date/Time: Jun 11, 2010
Abstract Submission Date: Dec 15, 2009
Paper Submission Date: Dec 15, 2009
Report as Spam


Following the great success of the first two ECI Conferences on Vaccine Technology, we are very excited to inform you of the progress to date for Vaccine Technology III.

Again, the goal is to provide a unique forum to bring together key leaders from academia, industry and government to share the latest developments in vaccine technology with a particular focus on the special challenges for Emerging markets and Developing World.

Confirmed speakers include:
Maharaj K. Bhan, DBT, India
John Boslego, PATH
Paolo Costantino, Novartis
Emilio Emini, Wyeth
Louis Fries, GlaxoSmithKline
Farshad Guirakhoo, Sanofi Pasteur
Ana Maria Henao-Restrepo, World Health Organization
Pablo Kuri, Sanofi-Aventis and UNAM
Altaf Lal, MSD Wellcome Trust Hilleman Laboratories
Didier Lapierre, GlaxoSmithKline
Anton Middelberg, The University of Queensland, Australia
Phil Minor, NIBSC
David Salisbury, SAGE
Alan Shaw, VaxInnate Corporation
Alex von Gabain, Intercell

We are inviting submission of abstracts for both oral and poster presentations in the following session categories.

I. Vaccine Target Identification & Validation
Session Chairs: David Weiner and Paula Alves

II. Vaccinology (Identifying and measuring immune response, delivery, vectors, adjuvants and glycosylated protein antigens)
Session Chairs: Annie de Groot and Kathrin Jansen

III. Bioprocess Development in Early Stages
Challenge of rapid process development and analytical methods development (Case studies: Dengue, malaria, TB, leishmaniasis, IVI)
Session Chairs: Herve Pinton and Amine Kamen

IV. Vaccines in Late Stage Development
Emphasis on scaleability, process robustness and cost of goods (Case Studies: Malaria, flu, mening C, multi valent HPV vaccine, setting up malaria clinic in Kenya)
Technology and analytical challenge
Session Chairs: John Aunins, Manon Cox and Mike Hoare

V. Recently Launched Vaccines (Availability, technical challenges, impact) Technology and Analytical challenges to meet capacity needs for worldwide use
Session Chairs: George Siber and Nathalie Garcon

VI. Technology Challenges in Developing World Market
Emphasis on capacity, cost of goods and distribution
• Stability
• Cold Chain
• Multi dose vials
• Cost and Capacity
Session Chairs: Barry Buckland and Mahima Datla

VII. Developing World: Progress in Key Regions
(India, South America, Mexico, China and Russia)
Session Chairs: Leda Castilho, Laura Palomares and Barry Buckland

VIII. Veterinary Vaccines
Session Chair: Robert Nordgren